TerminatedNot Applicable

Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.

Stopped: Could not recruit any subjects

United States4 participantsStarted 2014-06

Plain-language summary

This is a study comparing the effect of erythromycin or metoclopramide, 2 prokinetic drugs (Drugs which are known to speed up the emptying of the stomach or in other words to move the blood out of the stomach faster) given before endoscopy to patients with upper Gastrointestinal bleeding compared to patients who will not receive either of these medications before their endoscopy.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Patients younger than 18 yrs old or older than 80 yrs
✕. Patients who refuse to consent to be in our study
✕. Pregnant patients
✕. Prior use of prokinetics in the last 48 hours
✕. History of cardiac arrhythmia
✕. Allergy to erythromycin or metoclopromide
✕. Patients with QT prolongation (query 7)

What they're measuring

Erythromycin, Metoclopromide vs Control Enabling Visualization of the Entire Gastric Mucosa .

Timeframe: 45 minutes

Erythromycin, Metoclopromide vs Control Improving the Quality of Stomach and Duodenum Visualization

Timeframe: 45 minutes

Trial details

NCT IDNCT02017379

SponsorTexas Tech University Health Sciences Center, El Paso

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-09

Results submitted2021-02-10

View on ClinicalTrials.gov More Upper Gastrointestinal Bleeding trials